Showing 1 - 20 results of 1,482 for search '(( significant benefits decrease ) OR ( significant ((inter decrease) OR (step decrease)) ))', query time: 0.47s Refine Results
  1. 1
  2. 2
  3. 3

    Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

    Published 2024
    “…The middle row shows the directionality of spectral change for these significant SVM clusters during number trial conditions versus inter-trial intervals. …”
  4. 4
  5. 5

    Results of normal and wide step width (cm). by Fateme Khorramroo (18086501)

    Published 2025
    “…We aimed to investigate if wide step width changes the lower limb inter-joint coordination and its variability in flat feet individuals. …”
  6. 6

    Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

    Published 2025
    “…<div><p>Purpose</p><p>Statins are the most commonly used drugs worldwide. Besides a significant decrease in cardiovascular diseases (CVDs) risk, the use of statins is also connected with a broad beneficial pleiotropic effect. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  17. 17

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  18. 18

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
  19. 19
  20. 20